 Circadian infusion floxuridine patients metastatic renal cell carcinoma total patients metastatic renal cell carcinoma floxuridine infusion days monthly intervals drug external programmable pump time-modified circadian schedule dose patients undergone prior nephrectomy evaluable patients confidential interval partial response undergone prior nephrectomy undergone renal angioinfarction patients responses metastatic sites response primary kidney tumor median duration response groups patients weeks responsive site lungs treatment outpatient basis study limited definite activity floxuridine circadian schedule patients metastatic renal cell carcinoma responses metastasis patients prior nephrectomy